Distributed Bio, in collaboration with Charles River, offers a range of innovative products and services for antibody discovery and engineering. Their phage display VHH and scFv antibody libraries, including the Cosmic, Superhuman, Tungsten libraries, and Tumbler antibody optimization technology, are used to advance antibody research. This strategic partnership allows Charles River customers to access Distributed Bio's expertise and their expanded antibody team, while benefiting from Charles River's industry-leading scientists and comprehensive molecule development services.

With their integrated target-to-clinic portfolio, Distributed Bio and Charles River provide a complete end-to-end solution for therapeutic antibody programs. Additionally, they offer in vitro and in vivo pharmacology screening, safety pharmacology, IND-enabling studies, and biologics testing solutions. Stay updated with the latest news and insights from Distributed Bio by signing up for their newsletter.

Partner with them to strengthen your antibody discovery and development program